Stockreport

Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial Results

Kyntra Bio, Inc.  (KYNB) 
PDF SAN FRANCISCO, March 09, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio (Nasdaq: KYNB), formerly FibroGen (Nasdaq: FGEN), will announce fourth quarter and full year 2025 financia [Read more]